Cell Host & Microbe Compendium – Best of 2020, Published by CellPress

Intensive  research  focuses  on  optimizing  the  use  of  vaccine  adjuvants  to not only enhance, but orientate specific Th1 or Th2 adaptive immune responses  to  antigens. The COVID-19 pandemic has scientists developing novel life-saving treatments at breakneck speed.

Sartorius provides innovative high-throughput & automated solutions for faster vaccine discovery, characterization & development. Our groundbreaking Octet®, iQue® and Incucyte® advanced cell & protein analysis platforms provide insights at unprecedented speed, depth & scale, streamlining workflows to accelerate results - when it counts.

Read the full publication.